Effectiveness of Spironolactone in Terms of Galectin-3 Levels in Patients with Heart Failure with a Reduced Ejection Fraction in the Vietnamese Population

Background: Galectin-3 is a biomarker that has been demonstrated to play a significant role in myocardial fibrosis and remodeling in the pathogenesis of heart failure. Furthermore, spironolactone has the ability to control galectin-3 levels in heart failure patients. Objectives: The aim of our study...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Son Kim, Ngo, Toan Hoang, Lai, Tin Trung, Truong, Giang Khanh, Tran, Khoa Dang Dang, Vo, Phuong Minh, Nguyen, Phi The, Nguyen, Phi Hoang, Nguyen, Thuan Tuan, Nguyen, Oanh Thi Kim, Nguyen, Thang, Nguyen, Kien Trung, Tran, Hung Do
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858831/
https://www.ncbi.nlm.nih.gov/pubmed/36673621
http://dx.doi.org/10.3390/healthcare11020253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858831/
https://www.ncbi.nlm.nih.gov/pubmed/36673621
http://dx.doi.org/10.3390/healthcare11020253

Ejemplares similares